NCT01701076
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Kantonsspital St. Gallen Sankt Gallen, Switzerland
Clinical trial condition
Blood Protein Disorders
Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.
3,041 public trials
566 recruiting studies
Blood Protein Disorders trial results
NCT00047788
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Research Site New York, United States
- Research Site Edmonton, Alberta, Canada
- Research Site Halifax, Nova Scotia, Canada
- Research Site Hamilton, Ontario, Canada
NCT01132833
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +15 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
NCT00891592
- Conditions
- ALL, AML, Blood Protein Disorders, +21 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT01319422
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Yale University New Haven, Connecticut, United States
NCT00458822
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma
NCT02861287
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France
NCT00560391
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- Local Institution Prahran, Victoria, Australia
- Local Institution Toulouse, France
- Local Institution Vandœuvre-lès-Nancy, France
Completed
Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial
NCT02193698
- Conditions
- Abnormalities, Multiple, Blood Protein Disorders, Congenital Abnormalities, +11 more
- Locations
-
- Chiba University Graduate School of Medicine Department of neurology Chiba, Japan
NCT00133367
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Graft vs Host Disease, +27 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States